Radiobiology and cancer
PRINCIPAL INVESTIGATORS
- Arturo Navarro Martin
- Ferran Ferrer Gonzalez
- Juan Luis Ribes Bernal
- Isabel Linares Galiana
- Miquel Macia Garau
- Miguel Angel Berenguer Frances
- Evelyn Martinez Perez
- Maria Aranzazu Eraso Urién
- Anna Maria Boladeras Inglada
- Cristina Gutierrez Miguelez
CLINICAL RESEARCHERS
- Joel Mases Rosines
- Ines Guix Sauquet
- Ignacio Visus Fernandez De Manzanos
- Andrea Slocker Escarpa
- Leyre Asiáin Azcárate
- Maria Laplana Torres
- Dina Najjari Jamal
- Sonia Almendros Sanchez
- Nagore Garcia Exposito
- Héctor Pérez Montero
- Miriam Nuñez Fernandez
COLLABORATORS
- Silvia Comas Anton
PREDOCTORAL RESEARCHERS (R1)
- Mònica Pujol Canadell
SCIENTIFIC SUPPORT
- Pilar Izquierdo Trigo
- Rut Cañas Cortes
- Montserrat Ventura Bujalance
Cancer
Oncobell
Scientific production
11
PAPERS
Selected publications
- Casas, F; Valduvieco, I; Oses, G; Izquierdo, L; Archila, I; Costa, M; Cortes, KS; Barreto, T; Ferrer, F. Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival. CLINICAL AND TRANSLATIONAL ONCOLOGY. 10.1007/s12094-018-1931-3
- Cozzi S, Jamal DN, Slocker A, Laplana M, Tejedor AG, Krengli M, Guedea F, Gutierrez C . Second breast-conserving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patients.. JOURNAL OF CONTEMPORARY BRACHYTHERAPY. 10.5114/jcb.2019.84689
- Almendros S., Berenguer-Francés M., Ferrer-González F., Boladeras A., Guix I., Guedea F.. Predictive factors for abiraterone withdrawal syndrome [Factores predictivos del síndrome de retirada de abiraterona]. ACTAS UROLOGICAS ESPANOLAS. 10.1016/j.acuro.2019.01.003
Research highlights
PROJECTS
1 Ongoing project
3 Ongoing clinical trials
PUBLISHED WORKS
2 Clinical guidelines
1 Thesis
Selected projects
- Estudio de fase 3 aleatorizado, doble ciego y controlado con placebo de JNJ-56021927 en sujetos con cáncer de próstata localizado o localmente avanzado y de alto riesgo que están recibiendo tratamiento con radioterapia primaria (4/3/2016 – ) PI: BOLADERAS INGLADA, ANNA MARIA. Funder ref.: 56021927PCR3003.